SYNGENE INTERNATIONAL LTD Intrinsic Value
SYNGENE · Healthcare · Current price ₹417.45
Is SYNGENE INTERNATIONAL LTD undervalued?
DocStoX estimates the fair value of SYNGENE INTERNATIONAL LTD at ₹223 per share, versus the current market price of ₹417. That puts the stock about -46.5% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹112), Relative P/E (₹490), Graham floor (₹143). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹112 (bear) to ₹223 (base) to ₹490 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹417 versus an intrinsic value of ₹223, SYNGENE INTERNATIONAL LTD currently offers -46.5% of negative margin (i.e. a premium).
More on SYNGENE INTERNATIONAL LTD
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.